You have 9 free searches left this month | for more free features.

City

Nanjing (1)

Santiago (1)

Condition

Colorectal Neoplasms (1)

Multiple Sclerosis, Secondary Progressive (1)

Primary Progressive Multiple Sclerosis (1)

Overall Status

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Gu Yanhong (1)

Innobioscience SpA (1)

Collaborator

Pontificia Universidad Catolica de Chile (1)

Universidad Austral de Chile (1)

University of Chile (1)

Intervention

andrographolides (2)

capecitabine (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

andrographolides

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Colorectal Tumors Trial in Nanjing (Andrographolides, Capecitabine)

Terminated

Colorectal Neoplasms

Andrographolides
Capecitabine

Nanjing, Jiangsu, China

the First Affiliated Hospital of Nanjing Medical University

Jan 12, 2020

Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive Trial in Santiago (Andrographolides, )

Unknown status

Primary Progressive Multiple Sclerosis
Multiple Sclerosis, Secondary Progressive

Andrographolides
placebo

Santiago, Metropolitana, Chile

Multiple Sclerosis Centre, Pontificia Universidad Catolica de Ch

Oct 24, 2014